Manish Sahni, MD, at Centra Internal Medicine The FDA has officially approved oral semaglutide for chronic weight management, marking a historic milestone in obesity medicine
Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
For someone using a personalized weight loss program, these factors are part of the broader health profile that a licensed provider considers during an initial assessment
The influence of GLP-1 agonism on nicotine is likely mediated by classical reward circuitry in addition to aversion circuits
Another economy in Asia that you cover is India